Journal
PHARMACEUTICS
Volume 13, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13081174
Keywords
cancer; photothermal therapy; laser; clinical trial; magnetic nanoparticles; graphene; nanotubes; quantum dots; nanosheets; nanomaterials
Categories
Funding
- University of The Sciences in Philadelphia, PA, USA
Ask authors/readers for more resources
This review highlights the transition from traditional thermal therapies to laser-based photothermal therapies in cancer treatment, emphasizing the role of nanoparticles as photothermal agents. Studies have shown promising outcomes of photothermal therapy in both in vitro and in vivo settings, as well as in recent clinical studies.
In this review, advancement in cancer therapy that shows a transition from conventional thermal therapies to laser-based photothermal therapies is discussed. Laser-based photothermal therapies are gaining popularity in cancer therapeutics due to their overall outcomes. In photothermal therapy, light is converted into heat to destruct the various types of cancerous growth. The role of nanoparticles as a photothermal agent is emphasized in this review article. Magnetic, as well as non-magnetic, nanoparticles have been effectively used in the photothermal-based cancer therapies. The discussion includes a critical appraisal of in vitro and in vivo, as well as the latest clinical studies completed in this area. Plausible evidence suggests that photothermal therapy is a promising avenue in the treatment of cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available